Our Radiosurgery Doctors

Robert Sinha, M.D.

Dr. Sinha graduated summa cum laude in engineering from Rutgers University, N.J., and received his medical degree from the Robert Wood Johnson School of Medicine (formerly Rutgers Medical School) where he was a Merit Scholar. He completed his residency at the University of Pennsylvania, Philadelphia. He was the Chief of Radiosurgery in New Haven, CT for eight years prior to moving to the Bay Area in 2006.

Dr. Sinha specializes in the central nervous system (CNS), lung, head, and neck tumors. He has special training in treatments using the TrueBeam STx, BrainLab and Cyberknife Radiosurgery systems. He is trained in Intensity-Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) as well as RapicArc cancer treatment technologies. He is trained also in general radiation oncology methods for digestive tumors, lymphoma, gynecologic tumors and prostate cancer. In addition to these clinical specialties, he treats patients with breast cancer using breast brachytherapy, an alternative to traditional breast cancer radiation treatments.

Gordon Sakamoto, M.D.

Dr. Sakamoto received his medical degree, and completed his internship and residency, at Stanford University Medical Center. He also completed a fellowship in stereotactic radiosurgery at Stanford. He is a member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.

Al V. Taira, M.D.

Dr. Taira received his medical degree from Stanford University in 2005. He completed his residency training in Radiation Oncology at the University of Washington in Seattle in 2010. Prior to that, he worked for 10 years for the international business strategy consultancy Bain & Company. Dr. Taira has diverse clinical and research interests, with a focus on prostate, gynecologic and other cancers. He is first author on many scholarly research papers, including seven papers in the International Journal of Radiation Oncology in the last several years. He is active in national societies and was recently appointed to a four year term on the Expert Panel of the American College of Radiology Appropriateness Criteria committee which develops national guidelines for cancer radiotherapy.